Protective effect of aqueous and ethanolic extracts of Portulaca oleracea against cisplatin induced nephrotoxicity

Iranian Journal of Basic Medical Sciences

Volumn 13, Issue 2 SPRING, 2010, Pages 31-35

  Karimi, Gholamreza ^a   Khoei, Alireza ^b   Omidi, Abbas ^b   Kalantari, Mahmudreza ^b   Babaei, Javad ^b   Taghiabadi, Elahe ^b   Razavi, Bibi Marjan ^b  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Antioxidants; Cisplatin; Kidney; Portulaca oleracea; Toxicity

Indexed keywords

ALCOHOL; CISPLATIN; CREATININE; NITROGEN; PORTULACA OLERACEA EXTRACT; UREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AQUEOUS SOLUTION; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DOSE RESPONSE; DRUG DETERMINATION; DRUG EFFECT; DRUG MECHANISM; DRUG MEGADOSE; DRUG SCREENING; HISTOPATHOLOGY; KIDNEY INJURY; MALE; NEPHROTOXICITY; NONHUMAN; PORTULACA OLERACEA; PORTULACACEAE; RAT; RENAL PROTECTION; TREATMENT INDICATION; UREA NITROGEN BLOOD LEVEL;

PORTULACA OLERACEA; PORTULACACEAE; RATTUS;

EID: 77952776630     PISSN: 20083866     EISSN: 20083874     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Lim YY, Quah EPL. Antioxidant properties of different cultivars of Portulaca oleracea. Food Chem 2007; 103:734-740.
2. Brickell C. Encyclopedia of Gardening. London: Dorling Kindersley; 1992.
3. Chan K, Islam MW, Kamil M, Radhakrishnan R, Zakaria MNM, Habibullah M, et al. The analgesic and anti-inflammatory effects of Portulaca oleracea L. subsp. sativa (Haw.) Celak. J Ethnopharmacol 2000; 73:445-451.
4. Okwuasaba F, Ejika C, Parry O. Effects of extracts of Portulaca oleracea on skletal muscle in vitro. J Ethnopharmacol 1987; 27:55-63. (Pubitemid 18082812)
5. Radhakrishnan R,Zakaria MN, Islam MW, Chen HB, Kamil M, Chan K, et al. Neuropharmacological actions of Portulaca oleraceae L v. sativa (Hawk). J Ethnopharmacol 2001; 76:171-176.
6. Abas F, Lajis NH, Israf DA, Khozirah S, Kalsom YU. Antioxidant and nitric oxide inhibition activities of selected Malay traditional vegetables. Food Chem 2006; 95:566-573. (Pubitemid 41436426)
7. Cai Y, Luo Q, Sun M, Corke H. Antioxidant activity and phenolic compounds of 112 traditional Chinese medicinal plants associated with anticancer. Life Sci 2004; 74:2157-2184. (Pubitemid 38210440)
8. Simopoulos AP. Omega-3 fatty acids and antioxidants in edible wild plants. Biol Res 2004; 37:263-277.
9. Yen GC, Chen HY, Peng HH. Evaluation of the cytotoxicity, mutagenicity and antimutagenicity of emerging edible plants. Food Chem Toxicol 2001; 39:1045-1053.
10. Giaccone G. Clinical perspectives on platinum resistance. Drugs 2000; 4:9-17.
11. Lee KW, Jeong JY, Lim BJ, Chang Y-K, Lee S-J, Na K-R, et al. Sildenafil attenuates renal injury in an experimental model of rat cisplatin-induced nephrotoxicity. Toxicology 2009; 257:137-143.
12. Tsuruya K, Ninomiya T, Tokumoto M, Hirakawa M, Masutani K, Taniguchi M, et al. Direct involvement of the receptor-mediated apoptotic pathways in cisplatin-induced renal tubular cell death. Kidney Int 2003; 63:72-82. (Pubitemid 35463908)
13. Kuhlmann MK, Horsch E, Burkhardt G, Wagner M, Kohler H. Reduction of cisplatin toxicity in cultured renal tubular cells by the bioflavonoid quercetin. Arch Toxicol 1998; 72:536-540. (Pubitemid 28396292)
14. Baliga R, Zhang Z, Baliga M, Ueda N, Shah SV. In vitro and in vivo evidence suggesting a role for iron in cisplatin-induced nephrotoxicity. Kidney Int 1998; 53:394-401.
15. McClatchey KD. Clinical Laboratory Medicine London Williams & Wilkins; 1994.
16. Hammersen F. Histology. Munich: Urban and Schwarzenberg;1985.
17. Karimi G, Ramezani M, Tahoonian Z. Cisplatin nephrotoxicity and protection by milk thistle extract in rats. Evid Based Complement Alternat Med 2005; 2:383-386.
18. Heidman HT, Gerkens JF, Jackson EK, Branch RA. Attenuation of cisplatin induced nephrotoxicity in the rat by high salt diet, furosemide and acetazolamide. Arch Pharmacol 1985; 329:201-205.
19. Montine TJ, Borch RF. Role of endogenous sulfur containing nucleophiles in an in vitro model of cisdiamminedichloroplatinium- induced nephrotoxicity. Biochem Pharmacol 1990; 39:1751-1757.
20. Rao M, Rao MMJ. Protective effects of selenomethionine against cisplatin-induced renal toxcity in mice and rats. Pharm Pharmacol 1992; 50:687-691.
21. Maliakel DM, Kagiya TV, Nair CKK. Prevention of cisplatin-induced nephrotoxicity by glucosides of ascorbic acid and [alpha]-tocopherol. Exp Toxicol Pathol 2008; 60:521-527.
22. Gaedeke J, Fels LM, Bokemeyer C, Mengs U, Stolte H, Lentzen H. Cisplatin nephrotoxicity and protection by silibinin. Nephrol Dial Transplant 1996; 11:55-62.
23. Chan K, Islam MW, Kamil M, Radhakrishnan R, Zakaria MN, Habibullah M, et al. The analgesic and anti-inflammatory effects of Portulaca oleracea L. subsp. Sativa (Haw.) Celak. J Ethnopharmacol 2000; 73:445-451.
24. Deng J, Kohda Y, Chiao H, Wang Y, Hu X, Hewitt SM, et al. Interleukin-10 inhibits ischemic and cisplatin-induced acute renal injury. Kidney Int 2001; 60:2118-2128.
25. Ramesh G, Reeves WB. TNF-alpha mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity. J Clin Invest 2002; 110:835-842.